TransMedics Group Inc vs Utilities Select Sector SPDR Fund — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Utilities Select Sector SPDR Fund trades at $44.86. The key difference: Utilities Select Sector SPDR Fund is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | XLU | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | — |
52-Week High | $150.42 | $47.73 |
52-Week Low | $61.99 | $41.31 |
Enterprise Value | $2.94B | — |
Signals from Pluang's Aura AI — not financial advice
TransMedics (TMDX) trades at $73.47, down 0.69% with neutral technical signals. The stock shows strong profitability with 27% net margins and 45% ROE, though Q1 2026 earnings missed expectations. Recent strategic investment in European aviation logistics aims to expand the Organ Care System platform. Analyst consensus remains bullish with a $108.71 price target representing 48% upside potential.
Long-term growth prospects appear solid given TMDX's expanding transplant ecosystem, but near-term margin pressure from expansion investments and execution risks warrant caution. The company maintains competitive advantages in organ transplant logistics, though increased spending and competitive threats from alternatives like Strata Critical Medical present headwinds for shareholder returns.
XLU trades at $44.93, down 0.51% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. The ETF benefits from growing AI-driven electricity demand, highlighted by recent news of utility stocks gaining traction as data center power needs strain the grid. Support sits at $44, with resistance at $46.
Outlook is cautiously optimistic due to structural power demand tailwinds from AI and clean energy transitions, though regulatory risks and execution challenges pose headwinds. The ETF offers defensive exposure with dividend income, but investors should monitor utility sector capacity investments and interest rate sensitivity.
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →